Data / Medical devices / United States / Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc.: FDA-registered device maker in Woodinville, WA, United States, 17 510(k) clearances and 3 PMA approvals
Bio-Rad Laboratories, Inc. is registered with the FDA (registration 3032705) in Woodinville, WA, United States. It lists 39 device types. The FDA files 17 510(k) clearances and 3 PMA approvals under its listings, the newest dated May 31, 2007. 1 recall event names it as the recalling firm. Registered through 2026. FDA data exported November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 3032705
- FEI number
- 3002701146
- Address
- 14620 NE North Woodinville Way, Woodinville, WA, United States, 98072
- Owner or operator
- BIO-RAD LABORATORIES, INC. (3022521)
- Roles
- Contract manufacturer, Manufacturer, Manufacturer for export, Specification developer
- First device listed
- January 8, 2008
- Registered through
- 2026
- Brand names listed
- BIOPLEX 2200 ANA SCREEN RE, BIOPLEX 2200 ANA SCREEN RE Detector Calibration Pack, BIOPLEX 2200 ANA SCREEN RE Detector Cleaning Pack, BioPlex 220 Celiac IgG kit, BioPlex 2200 25-OH Vitamin D Calibrator Set, BioPlex 2200 25-OH Vitamin D Control Set, BioPlex 2200 25-OH Vitamin D Kit, BioPlex 2200 25-OH Vitamin D Reagent Pack and more
Devices it lists
510(k) clearances
The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.
| Decided | 510(k) number | Device | Product code | Decision | Applicant | Source |
|---|---|---|---|---|---|---|
| January 16, 2004 | K033915 | MODIFICATION TO SERAQUEST EB VCA IGG | LSE | Substantially Equivalent | Quest Intl., Inc. | accessdata.fda.gov |
| January 15, 2004 | K033780 | MODIFICATION TO SERAQUEST VCA IGM | LJN | Substantially Equivalent | Quest Intl., Inc. | accessdata.fda.gov |
| November 2, 1999 | K991975 | SERAQUEST EB NA IGG | LSE | Substantially Equivalent | Quest Intl., Inc. | accessdata.fda.gov |
| January 13, 1999 | K982485 | SERAQUEST CMV IGM | LFZ | Substantially Equivalent | Quest Intl., Inc. | accessdata.fda.gov |
| October 16, 1998 | K982281 | SERAQUEST RUBELLA IGM | LFX | Substantially Equivalent | Quest Intl., Inc. | accessdata.fda.gov |
| April 23, 1998 | K980059 | SERAQUEST MUMPS IGG | LJY | Substantially Equivalent | Quest Intl., Inc. | accessdata.fda.gov |
| November 5, 1997 | K972295 | SERAQUEST VZV IGG | LFY | Substantially Equivalent | Quest Intl., Inc. | accessdata.fda.gov |
| January 22, 1997 | K963282 | SERAQUEST HSV IGG | LGC | Substantially Equivalent | Quest Intl., Inc. | accessdata.fda.gov |
| September 4, 1996 | K961053 | SERAQUEST RUBELLA IGG | LFX | Substantially Equivalent | Quest Intl., Inc. | accessdata.fda.gov |
| June 17, 1996 | K960092 | SERAQUEST TOXOPLASMA IGG | LGD | Substantially Equivalent | Quest Intl., Inc. | accessdata.fda.gov |
| February 23, 1996 | K954191 | SERAQUEST CMV IGG | LFZ | Substantially Equivalent | Quest Intl., Inc. | accessdata.fda.gov |
| December 20, 1991 | K911590 | IMMUNOWELL BORRELIA (LYME)TEST | LSR | Substantially Equivalent | General Biometrics, Inc. | accessdata.fda.gov |
| March 21, 1989 | K890768 | PNEUMOCYSTIS CARINII IMMUNOFLUORESCENCE TEST KIT | LYF | Substantially Equivalent | Genetic Systems Corp. | accessdata.fda.gov |
| August 22, 1985 | K852237 | LEGIONELLA IMMUNOFLUORESCENT ANTIBODY TEST KIT | LHL | Substantially Equivalent | Genetic Systems Corp. | accessdata.fda.gov |
| January 18, 1982 | K813592 | QUANTAFLUOR FLUORESCENT TEST REAGENTS | DHN | Substantially Equivalent | Kallestad Laboratories, Inc. | accessdata.fda.gov |
| April 14, 1981 | K810863 | KALLESTAD HEP-2 CELL LINE SUBSTRATE | DBM | Substantially Equivalent | Kallestad Laboratories, Inc. | accessdata.fda.gov |
| September 7, 1978 | K780899 | FLUORESCENT ANTI-NATIVE DNA TEST | DHN | Substantially Equivalent | Kallestad Laboratories, Inc. | accessdata.fda.gov |
PMA approvals
Premarket approvals this establishment lists, with the supplements the FDA has decided since.
| Approved | PMA number | Device | Product code | Supplements | Latest decision | Source |
|---|---|---|---|---|---|---|
| May 31, 2007 | P060034 | BIO RAD MONOLISA ANTI-HBC IGM EIA | SEI | 7 | March 19, 2014 | accessdata.fda.gov |
| April 27, 2007 | P060031 | BIO-RAD MONOLISA ANTI-HBC EIA | SEI | 7 | December 12, 2013 | accessdata.fda.gov |
| August 25, 2006 | P050048 | MONOLISA ANTI-HBS EIA | SEI | 9 | April 18, 2025 | accessdata.fda.gov |
Recalls
Recall events where this establishment is the recalling firm, matched on its FEI.
| Initiated | Event | Class | Status | Product | Reason | Source |
|---|---|---|---|---|---|---|
| May 30, 2025 | 97106 | Class II | Ongoing | Platelia Toxo IgM Catalog Number 26211 UDI Code: 03610520005552 The Platelia Toxo IgM assay is a semi-quantitative immunocapture enzyme immunoassay kit for the detection of IgM antibodies to Toxoplasma gondii in human se | Due to a risk of false positive results that could lead to unnecessary medical treatment. | accessdata.fda.gov |
Compare with other makers
- All makers of Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control
- All makers of Enzyme Linked Immunoabsorbent Assay, Mumps Virus
- All makers of Reagents, Antibody, Legionella, Direct & Indirect Fluorescent
- All makers of Epstein-Barr Virus, Other
- All makers of Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus
- All makers of Multi-Analyte Controls, All Kinds (Assayed)
Updated September 4, 2025. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.